Effect of nocturnal oxygen therapy on nocturnal hypoxemia and sleep apnea among patients with chronic obstructive pulmonary disease traveling to 2048 meters: a …

L Tan, TD Latshang, SS Aeschbacher… - JAMA network …, 2020 - jamanetwork.com
Importance There are no established measures to prevent nocturnal breathing disturbances
and other altitude-related adverse health effects (ARAHEs) among lowlanders with chronic …

Effect of dexamethasone on nocturnal oxygenation in lowlanders with chronic obstructive pulmonary disease traveling to 3100 meters: a randomized clinical trial

M Furian, M Lichtblau, SS Aeschbacher… - JAMA network …, 2019 - jamanetwork.com
Importance During mountain travel, patients with chronic obstructive pulmonary disease
(COPD) are at risk of experiencing severe hypoxemia, in particular, during sleep. Objective …

Sleep and breathing disturbances in patients with chronic obstructive pulmonary disease traveling to altitude: a randomized trial

TD Latshang, RPM Tardent, M Furian, D Flueck… - Sleep, 2019 - academic.oup.com
Abstract Study Objectives Patients with chronic obstructive pulmonary disease (COPD) have
impaired pulmonary gas exchange near sea level. The purpose of the current study was to …

Effect of nocturnal oxygen therapy on exercise performance of COPD patients at 2048 m: data from a randomized clinical trial

S Gutweniger, TD Latshang, SS Aeschbacher… - Scientific Reports, 2021 - nature.com
This trial evaluates whether nocturnal oxygen therapy (NOT) during a stay at 2048 m
improves altitude-induced exercise intolerance in lowlanders with chronic obstructive …

Counseling Patients with Chronic Obstructive Pulmonary Disease Traveling to High Altitude

KE Bloch, TM Sooronbaev, S Ulrich… - … Altitude Medicine & …, 2023 - liebertpub.com
Bloch, Konrad E., Talant M. Sooronbaev, Silvia Ulrich, Mona Lichtblau, and Michael Furian.
Clinician's corner: counseling patients with chronic obstructive pulmonary disease traveling …

Nocturnal heart rate and cardiac repolarization in lowlanders with chronic obstructive pulmonary disease at high altitude: data from a randomized, placebo-controlled …

M Bisang, TD Latshang, SS Aeschbacher… - Frontiers in …, 2021 - frontiersin.org
Background: Chronic obstructive pulmonary disease (COPD) is associated with
cardiovascular disease. We investigated whether sleeping at altitude increases nocturnal …

Exercise performance and symptoms in lowlanders with COPD ascending to moderate altitude: randomized trial

M Furian, D Flueck, TD Latshang… - … journal of chronic …, 2018 - Taylor & Francis
Objective To evaluate the effects of altitude travel on exercise performance and symptoms in
lowlanders with COPD. Design Randomized crossover trial. Setting University Hospital …

Altitude travel in patients with pulmonary hypertension: randomized pilot-trial evaluating nocturnal oxygen therapy

M Lichtblau, S Saxer, TD Latshang… - Frontiers in …, 2020 - frontiersin.org
Introduction: Stable patients with pulmonary arterial or chronic thromboembolic pulmonary
hypertension (PH) wish to undergo altitude sojourns or air travel but fear disease worsening …

The Effect of Chronic Altitude Exposure on COPD Outcomes in the SPIROMICS Cohort

R Suri, D Markovic, H Woo, M Arjomandi… - American Journal of …, 2024 - atsjournals.org
Rationale: Individuals with COPD have airflow obstruction and maldistribution of ventilation.
For those living at high altitude, any gas exchange abnormality is compounded by reduced …

Effect of altitude and acetazolamide on sleep and nocturnal breathing in healthy lowlanders 40 y of age or older. Data from a randomized trial

LC Graf, M Furian, K Bitos, M Mademilov, A Abdraeva… - Sleep, 2023 - academic.oup.com
Abstract Study Objectives To assess altitude-induced sleep and nocturnal breathing
disturbances in healthy lowlanders 40 y of age or older and the effects of preventive …